CORD-19:02d18b4f484a0420c21595a95b8765125d4a484c / 13032-13250
Annnotations
CORD-19_Custom_license_subset
{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T75","span":{"begin":0,"end":218},"obj":"Sentence"}],"text":"ACE2 treatment by means of gene therapy or recombinant protein indeed improved hypertension, atherosclerosis, and kidney diseases (Diez-Freire et al., 2006; Dong et al., 2008; Lovren et al., 2008; Oudit et al., 2010) ."}
CORD-19-Sentences
{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T75","span":{"begin":0,"end":218},"obj":"Sentence"},{"id":"TextSentencer_T75","span":{"begin":0,"end":218},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"ACE2 treatment by means of gene therapy or recombinant protein indeed improved hypertension, atherosclerosis, and kidney diseases (Diez-Freire et al., 2006; Dong et al., 2008; Lovren et al., 2008; Oudit et al., 2010) ."}
CORD-19-PD-MONDO
{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T29","span":{"begin":79,"end":91},"obj":"Disease"},{"id":"T30","span":{"begin":93,"end":108},"obj":"Disease"},{"id":"T31","span":{"begin":114,"end":129},"obj":"Disease"}],"attributes":[{"id":"A29","pred":"mondo_id","subj":"T29","obj":"http://purl.obolibrary.org/obo/MONDO_0005044"},{"id":"A30","pred":"mondo_id","subj":"T30","obj":"http://purl.obolibrary.org/obo/MONDO_0005311"},{"id":"A31","pred":"mondo_id","subj":"T31","obj":"http://purl.obolibrary.org/obo/MONDO_0001343"},{"id":"A32","pred":"mondo_id","subj":"T31","obj":"http://purl.obolibrary.org/obo/MONDO_0005240"}],"text":"ACE2 treatment by means of gene therapy or recombinant protein indeed improved hypertension, atherosclerosis, and kidney diseases (Diez-Freire et al., 2006; Dong et al., 2008; Lovren et al., 2008; Oudit et al., 2010) ."}
CORD-19-PD-HP
{"project":"CORD-19-PD-HP","denotations":[{"id":"T7","span":{"begin":79,"end":91},"obj":"Phenotype"},{"id":"T8","span":{"begin":93,"end":108},"obj":"Phenotype"},{"id":"T9","span":{"begin":114,"end":129},"obj":"Phenotype"}],"attributes":[{"id":"A7","pred":"hp_id","subj":"T7","obj":"http://purl.obolibrary.org/obo/HP_0000822"},{"id":"A8","pred":"hp_id","subj":"T8","obj":"http://purl.obolibrary.org/obo/HP_0002621"},{"id":"A9","pred":"hp_id","subj":"T9","obj":"http://purl.obolibrary.org/obo/HP_0000112"}],"text":"ACE2 treatment by means of gene therapy or recombinant protein indeed improved hypertension, atherosclerosis, and kidney diseases (Diez-Freire et al., 2006; Dong et al., 2008; Lovren et al., 2008; Oudit et al., 2010) ."}
CORD-19-PD-UBERON
{"project":"CORD-19-PD-UBERON","denotations":[{"id":"T41","span":{"begin":114,"end":120},"obj":"Body_part"}],"attributes":[{"id":"A41","pred":"uberon_id","subj":"T41","obj":"http://purl.obolibrary.org/obo/UBERON_0002113"}],"text":"ACE2 treatment by means of gene therapy or recombinant protein indeed improved hypertension, atherosclerosis, and kidney diseases (Diez-Freire et al., 2006; Dong et al., 2008; Lovren et al., 2008; Oudit et al., 2010) ."}